Introduction
A number of patients with ischemic cerebrovascular stroke suffer a progressive deterioration secondary to massive cerebral ischemia, edema, and increased intracranial pressure (ICP). The evolution is often fatal. Stroke is the second -leading cause of death worldwide. Life-threatening, complete middle cerebral artery (MCA) infarction occurs in up to 10% of all stroke patients, and this may be characterized as massive hemispheric or malignant space -occupying supratentorial infarcts. Malignant, space -occupying supratentorial ischemic stroke is characterized by mortality up to 80%, several reports indicated a beneficial effect of hemicraniectomy in this situation, converting the closed, rigid cranial vault into a semi open. The main cause of death encountered in these patients is severe postischemic brain edema leading to raised intracranial pressure, clinical deterioration, coma and death. The result is dramatic decrease in ICP and a reversal of the clinical and radiological signs of herniation. For these reasons, decompressive craniectomy has been increasingly proposed as a lifesaving measure in patients with large, space-occupying hemispheric infarction. Recent successes with intra-venous and intra-arterial thrombolytic therapy have resulted in an increased awareness of stroke as a medical emergency. Thus, increasing numbers of patients are being evaluated in the early hours following the ictal event. In the process of gaining more experience in the early management of patients with acute ischemic stroke, it has become clear that in a number of these patients a progressive and often fatal deterioration secondary to mass effect from the edematous, infarcted tissue occurs. An increasing body of experimental and clinical evidence suggests that some of these patients may benefit from undergoing a decompressive craniectomy. But, the timing and indications for this potential lifesaving procedure are still debated. The objectives of this chapter are; • To help better define the selection criteria for performing the surgery in case of supratentorial infarctions, • To assess the immediate outcome in terms of time conscious recovery and survival • To assess long term outcome and quality of life, using standard and functional assessment scales Complications have been reported in the literature when hemicraniectomy has been completed after cerebral infarction. Malignant cerebral ischemia occurs in a significant number of patients who undergo emergency evaluation for ischemic stroke. This patient
Historical background
Decompressive craniectomy procedures have been used to relieve increased ICP and cerebral oedema caused by a variety of pathological events. This technique (decompressive craniectomy) first applied in 1905. (10) In 1905, Cushing reported the use of this procedure to relieve the pressure caused by the growth of an intracranial tumour. (1, 39, 66) Since then, surgical decompression has been reported as a treatment option for traumatic head injury, (24, 26, 53, 42) subdural haematoma, (9, 56, 38) oedema resulting from vasospasm secondary to subarachnoid haemorrhage, (17) encephalitis, (39, 63) intracerebral haematoma, (13) cerebral venous and dural sinus thrombosis, (69) cerebellar infarction, (28, 31, 59 ) and supratentorial cerebral ischemia. (65, 45) Non randomized and randomized control data published are reviewed and data are analyzed, enrolling result from recent and earlier studies. In the 1950s and 60s, a number of reports were published in which the authors described cases of massive cerebral ischemia accompanied by acute and severe brain swelling. (1) These cases were often fatal, with the oedema caused by the infarct producing a "pseudotumour" increasing in pressure within the cranial vault. (44) In 1968, Greenwood used surgical intervention in the treatment of such cases, which decreased the mortality rate to below 50% as reported, (24) in his series of 9 patients with acute infarction involving the MCA or ICA, decompressive hemicraniectomy as well as resection of the necrotic parenchyma were performed. Six of these patients survived, although 3 suffered postoperatively from severe disability. In their report in 1971, Kjellberg and Prieto described a bifrontal decompressive craniectomy procedure for the treatment of a massive infarction; however, the patient did not survive. (41) In 1981, Rengachary and co-workers reported the first cases in which straightforward craniectomy were undertaken, without removal of necrotic brain tissue. (57) Since that study, more additional cases of hemicraniectomy and some with bilateral craniectomy have been reported in the treatment of massive cerebral ischemia. (50) Significant retrospective data support the hypothesis that decompressive hemicraniectomy decreases mortality rates due to this disease entity. Three randomized controlled studies shed light on these issues and enhance the quality of evidence revolving around this procedure.
"Malignant" cerebral infarction
Ischemic cerebral infarction is associated with a high rate of morbidity and mortality, which are highest when lesions involve the trunk of one or more of the main cerebral vessels. In fact, occlusion of either the distal Internal Carotid Artery (ICA) or proximal (MCA) trunk has been characterized as a "malignant" stroke in both clinical and animal studies, and these are the reason why we are considering this topic in relation with brain infarction in MCA territory. (15, 27) Of all cases with supratentorial infarctions in which an autopsy is performed, 13% are shown to suffer from severe brain swelling after an infarction involving the entire distribution of the ICA or MCA. (46, 49) Severe cerebral oedema can lead to herniation of cerebral structures through the tentorium or falx, as well as the brainstem structures through the foramen magnum. In fact, transtentorial herniation has been cited as the probable cause of death in many of these cases of malignant stroke. Bounds et al reviewed 100 autopsy cases of patients in whom an infarction involving the ICA distribution had been diagnosed. (5) Thirty-one patients died of tentorial herniation, which was the only neurological cause of death in all the cases reviewed. The prognosis for patients who suffer a "malignant" cerebrovascular accident (CVA) is poor, with death occurring usually within the first 4 to 5 days. In this subset of patients, a mortality rate of 78% (estimated to be between 50% -78%) was observed, (27) all deaths were attributed to transtentorial herniation, which occurred within 2 to 7 days (median 4 days). Similarly, in another set of data 81% of patients with malignant CVA died, and all deaths occurred within 5 days and were caused by herniation, (62, 64) given the poor prognosis in these patients, it is of critical importance to recognize imaging or clinical characteristics suggestive of such a progressive and rapid deterioration. In patients who suffer a malignant CVA the clinical course is generally predictable. The clinical course in these patients is uniform, with clinical deterioration developing within the first 2 to 3 days after stroke. Presenting symptoms may include the sudden onset of hemiplegia, homonymous hemianopsia, forced eye and head deviation toward the lesion side, and aphasia. Precipitous coma and papillary dilation usually occur together following the initial symptoms, (7, 12) in the absence of further intervention, death occurs. To establish objective criteria for aggressive intervention, many investigators have measured intracranial pressure (ICP) once significant clinical deterioration is apparent. In an early study patients in whom ICP values were greater than 15 mm Hg did not survive the malignant infarct. (61) In subsequent studies other authors have shown that a fatal outcome occurred in most cases when the level was greater than 30 mm Hg. (7, 29, 51, 59, 74) In addition to clinical findings, neuroimaging criteria can help to identify those patients at particular risk for a malignant infarction in the early phase of their stroke. In patients with malignant CVA, a large area of parenchymal hypodensity in the MCA territory is often visualized on the admission CT scans (Figure 1) . (59, 64, 74, 78) With progressive clinical deterioration, CT-demonstrated signs may also include mass effect, effacement of the basal cisterns, compression of the ventricular system, a shift of midline structures, (78, 74) and herniation of tissue through the falx, foramen magnum, or tentorium. These patients present clinically with progressive deterioration of consciousness within the first 2 days. Thereafter, symptoms of transtentorial herniation occur within 2 to 4 days after onset of stroke. This clinical presentation is accompanied by early CT signs of major infarct during the first 12 hours after stroke, (74) as no model of medical treatment has been proven superior to the others, treatment options may vary, depending on each clinic protocol. The value of conventional therapies in this condition, as in others of raised ICP, consisting of artificial ventilation, osmotherapy, and barbiturate administration, has been a subject of debate. 
Rationale for decompressive craniectomy and experimental studies
Cerebral ischemia results in oedema formation in and around the ischemic area, the larger the area of the infarction, the greater the extent of oedema. In the case of malignant CVA, the entire vascular distribution of the MCA, and possibly the anterior cerebral artery, is compromised. A severe oedematous response ensues throughout a large area. (61) Oedema is responsible for the parenchymal hypodensity that is demonstrated on CT scanning. (37, 56) One of the fundamental pathophysiological processes after cerebrovascular stroke is the development and propagation of an escalating cycle of brain swelling and an increase in ICP. The goals of the clinical management consist of interrupting this cycle by controlling ICP and maintaining cerebral perfusion pressure and cerebral blood flow to avoid brain ischemia. This management strategy has been developed as a result of reported strong correlations between uncontrollable high ICP and high rates of morbidity and mortality. The relationship between high ICP and poor outcome has been demonstrated consistently in both single-centre and multicenter studies and the ability to bring elevated ICP under control has long been considered a requirement for improving outcome of patients with severe head injuries. Progressive brain oedema and the exacerbating effect it has on increasing ICP can cause the area of damaged brain to extend. Within the confined cranial vault, the oedematous tissue places pressure against surrounding normal parenchyma. This is evidenced by the changes seen on CT scanning (Figure 2) . Intracranial hypertension results in decreased cerebral perfusion pressure and therefore decreasing blood supply throughout the cerebrum. Because of the increase in mechanical pressure and ICP, other major cerebral vessels may be compressed by the expanding tissue, against dural edges or against the skull. The result is secondary ischemia and a further expansion of the infracted area. A decrease in ICP allows for an increase in cerebral perfusion pressure, aiding blood flow to the ischemic area, optimizing circulation to the damaged area through collateral vessels. Because hemicraniectomy alone may improve blood flow in the ischemic area, surgical resection of the infracted tissue should not be conducted in these patients. Although such resection or "strokectomy" has been associated with postoperative improvements in some cases, it is impossible in all the cases to differentiate at surgery between ischemic tissue and necrotic tissue. (34, 57) Being poorly delineated from necrotic tissue, the ischemic area may possibly be damaged or removed upon resection of the infarct.
Timing and indications of surgery
Hemicraniectomy has for a long time been used as a last resort to prevent impending death after all medical therapies have been attempted. The surgical procedure certainly preserves life, as evidenced by decreased mortality rates when compared with patients who undergo medical therapy alone. (61) In many of the reported cases, the symptoms of a severe herniation syndrome, fixed, dilated pupils, precipitous coma, cardiorespiratory difficulties and decerebrate posturing, were used to indicate the need for decompressive surgery. (37, 35, 40) Patients suffering malignant CVA receive antioedema medical treatment and hyperventilation or tissue plasminogen activator, (70) before considering a decompressive craniectomy. Usually, an initial reversal of symptoms, such as the degree of pupillary dilation, occurs with aggressive medical treatment. After its initial effectiveness, however, additional medical therapeutic efforts often fail to control or prevent herniation. In the case of massive cerebral ischemia, the effectiveness of such medical therapy is severely limited, at best, as evidenced by the high mortality rates observed in the absence of surgical intervention. In the case of stroke which is typically not treated surgically, physicians may wait too long to intervene surgically. Once the pupils are fixed and a deep coma has indicated an irreversible decline of cerebral function, surgery should not be performed. (57) Evaluation of experimental findings suggests that, early surgical decompressive surgery for the treatment of massive cerebral ischemia may limit the extension of the infarction and reduce morbidity. (14, 21) Craniectomy can decrease the infarct volume and improve neurological outcome in a rat model of MCA occlusion when surgery is completed early (1 hour postictus). (20) Similar results are found when surgery was completed 4 hours postictus. In the 4-hour treatment group, outcome and infarct volume were significantly better as compared with those observed in control animals and animals surgically treated at 12, 24 and 36 hours postictus. Animals treated at these later time periods improved, but no significant differences were reported among these three groups and the control group. (14) When patients who suffer malignant CVA were surgically treated on average 21 hours postictus, there was a greater decrease in mortality rate and length of stay in the intensive care unit as compared with patients who underwent surgery an average 39 hours postictus. There was also a trend of improved Barthel Index (BI) scores demonstrated at follow-up for patients in the earlier surgical group. Several factors need to be considered to optimize both the timing and the indication for decompressive craniectomy (Table 1) . (26, 30, 32, 48, 71, 72) 
Predictors of malignant cerebral edema
Severely compressive brain edema is associated with significant mortality and morbidity. From a pathophysiological view, early intervention could minimize secondary ischemia of viable tissue around the infarcted area and possibly prevent herniation. Optimal utility of this procedure would require identifying the population that is most likely to benefit in a way that meets patient's expectations as well as those of their families and caretakers. By using diffusion weighted MR imaging, a stroke volume greater than 145 cm3 within 14 hours of onset of stroke symptoms has 100% sensitivity and 94% specificity for predicting the progression to malignant edema. (52) Additionally, in patients who suffered a massive MCA territory stroke, stroke volume greater than 50% of the MCA territory were identified, high white blood cell count, additional involvement of the anterior or posterior cerebral artery, systolic blood pressure higher than 180 mm Hg within 12 hours of stroke onset, and a history for the progression toward malignant edema. (36) Patients with an NIHSS score of 20 or greater on admission or who present with nausea or emesis are at high risk for developing malignant cerebral edema. (43) In addition to clinical and radiographic risk factors, serum levels of the astroglial protein S100B have been shown to be predictive of malignant cerebral edema with 94% sensitivity and 83% specificity (for a value of 1.03 mg/L at 24 hours from the ischemic event). (19) This may become a useful monitoring tool at crucial clinical time points at which the development of cerebral edema is believed to be an imminent possibility, once a commercially available bedside kit is available.
Time window for surgery
The question of the optimal time window for intervention has not yet been completely elucidated. (4, 26, 30, 32, 48, 71, 72) Although the pooled data from the European trials seem to show benefit from early surgery, only a small number of patients was included in the late group in the HAMLET, (30) and definite conclusions cannot be drawn at this time. Another sours of data, did not demonstrate a difference in outcome based on timing. (26) Clear definition of a time window for intervention will be essential to creating treatment guidelines. With that purpose in mind, 2 additional randomized control trials (RCTs), The North American HeADDFIRST (Hemicraniectomy And Durotomy on Deterioration From Infarction Related Swelling Trial), aimed to evaluate patient outcome after hemicraniectomy within 96 hours from symptom onset, the HeMMI trial (Hemicraniectomy for Malignant Middle cerebral artery Infarcts) in the Philippines is studied patient morbidity and mortality after decompressive surgery within 72 hours from symptom onset.
Intracranial pressure monitoring
Intracranial pressure monitoring has been recommended as a guide to surgical timing. (81, 62) A measurement of greater than 25 mm Hg has been used despite attempts at medical therapy as an indicator for surgical intervention. (7, 59 ) Increased ICP measurements are preceded by the constellation of clinical signs and symptoms constituting the "malignant CVA syndrome;" thus, the usefulness of ICP monitoring in these cases has been questioned. But, brain tissue shifts rather than raised ICP are probably the most likely cause of the initial decrease in consciousness.
Neuroimaging studies
Extensive MCA infarction with oedema in greater than 50% of the MCA territory can be identified early after the ictal event on CT scans, and it is observed on the initial CT scan in approximately 69% of the reviewed cases by Hacke et al. (27) Parenchymal hypodensity in greater than 50% of the MCA territory is highly indicative of a progressive clinical course, leading to severe morbidity or death. With current, newer CT scanners, parenchymal hypodensity can be seen and followed soon after symptom onset (Figure 3) . In another set of data, most of the patients had at least two CT scans, one, within first 4 days after stroke and in some series within the first 12 hours after symptom onset, and the second one with the deterioration of symptoms and or after surgery (Figures 4 and 5) . (64, 65) Fig. 4 . CT scan, one day after hemicraniectomy (in which large frontoparieto-occipital bone was removed), revealing the resence of midline shift In a study conducted to examine only the prognostic value of midline shift, it was suggested that at 32 hours after the occurrence of cerebral infarction, a shift of the third ventricle greater than 4 mm was indicative of a fatal outcome. (23) Regardless of its potential for prognostic significance however, midline shift is not visualized as early on CT scanning as is parenchymal hypodensity (Figure 1) . Early changes demonstrated on CT scans are also an indicator of the viability of collateral circulation. Cerebral Angiography was performed (Figure 6 ) in patients in whom stroke was demonstrated early with CT scanning. Comparing the angiographic findings with those obtained using CT scanning, the authors observed that parenchymal hypodensity in greater than 50% of the MCA territory was predictive of poor collateral circulation, as evidenced by the angiographic study. (74) These findings are important, because in patients with adequate collateral circulation, decompressive hemicraniectomy may not be necessary. From neuroradiological studies it has been well recognized that "early visual radiolucency" in the CT examination is a negative outcome predictor. Continued refinements of newer imaging techniques such as diffusion / perfusion magnetic resonance will lead to an earlier identification of those patients more likely to benefit from early decompressive craniectomy. (Figures 7 and 8 ) Fig. 7 . MRI T2-weight diffusion, revealing R MCA territory infarction with early cytotoxic oedema 
Patient age and surgical age limit
The age of patients undergoing surgical intervention reported in the reviewed series ranged from 11 to 70 years of age. Based on data provided in the literature, it was impossible to determine if a certain age range of patients benefits more from surgical decompression. Most investigators, however, noted that they are more aggressive in performing hemicraniectomy in young patients in whom CVA has occurred and that the young seemed to benefit more from the procedure. By dividing patients by age in those younger than, and older than 50 years of age, it is found that patients under the age of 50 years made a good functional outcome (Barthel Index scores > 60 [100 = independent, 60-95 minimum assistance, and < 60 = dependent]), but not at all the patients over 50 years of age was this observed at follow-up examinations. (7) In theory and in practice, it would seem that younger patients with ischemic stroke would benefit from early decompressive surgery for the following reasons:
• Their brains are less atrophied, allowing less room for oedematous expansion within the cranial vault. Individuals aged 50 years and younger have been identified as benefiting more from bilateral decompressive craniectomy in cases of subarachnoid haemorrhage because of their unatrophied brains, as compared with those over 50 years of age.
• The ventricular system in younger persons is smaller than in older persons.
• It has been proposed that the oedematous response to ischemia is greater in younger individuals. Randomized trials to date have focused on patients 60 years of age and younger, thus leaving us with very few data regarding patients older than 60 years of age. The HAMLET displayed conflicting results with previous review series (30) with a trend toward better outcome in the upper age categories (51-61 years). These results raised questions about the existence of an age limit for surgical benefit. The DESTINY RCT will shed more light on the impact of surgery in patients older than 60 years. (33) In patients older than 60 years of age, assessing outcome following decompressive craniectomy of malignant MCA infarction, mortality rate and functional outcome, as measured by Barthel Index (BI) and modified ranking scale (mRS), were significantly worse in patients older than 60 years of age following decompressive craniectomy. (3) Age is an important factor to consider in patient selection for surgery. However, cautious interpretation of the results is required because the outcome scores that were used only measure physical disability, whereas other factors, including psychosocial, financial, and caregiver burden, should be considered in addition to age alone.
Dominant hemisphere infarction
As a rule, investigators in the past did not undertake surgery in patients with dominant hemisphere infarctions. The loss of communicative abilities and a plegic dominant upper extremity were judged to be too damaging. Analysis of recent evidence suggests that considering a dominant hemisphere infarction to be a contraindication to surgery may be too harsh a criterion. (60, 65) Functionally, the patients with the dominant hemisphere infarct who underwent hemicraniectomy were not significantly different from those patients who underwent craniectomy after CVA in the nondominant hemisphere. Therefore, surgery can be considered in patients with dominant hemisphere infarction, especially if some residual language function is present at admission. While the fear of complete aphasia was classically the reason behind the refusal to operate on large dominant hemispheric strokes, data have suggested that nondominant hemispheric injuries leading to serious depression and neglect can be as disabling as aphasia during the rehabilitation process. (76) Additionally a subset analysis in the DECIMAL trial showed no difference in the mRS scores of survivors with or without aphasia at 1 year; in addition, all surgical survivors agreed with the decisions to undergo surgery when asked retrospectively, including patients still experiencing aphasia. (72) Stroke laterality and its correlation with outcome (29, 30, 33, 34, 71) have also been the subject of subgroup analysis in other trials and controlled and uncontrolled studies have shown no predicative value for outcome related to laterality. There has been interest in identifying which patients will develop malignant cerebral oedema after massive infarcts, patients at high risk ( Table 2) .
Inclusion criteria Exclusion criteria Age 18 -60 years
Prestroke mRS score ≥ 2 NIHSS score nondominant hemisphere > 18 dominant hemisphere > 20
Prestroke score Barthel Index < 95
Imaging -documented unilateral infraction. MCA at least 2/3 of territory and at least part of basal ganglia. ± Additional infarctions in ACA or PCA territory. Ipsilateraly.
GCS < 6
Time -onset of symptoms bilateral -pupils fixed and dilated Other brain related diseases Haemorrhagic transformation of the infarct Life expectancy < 3 years Other related disease/ conditionsaffecting outcome. Especially coagulopathy/ systemic blooding disorders. Pregnancy. Contraindication for anaesthesia Table 2 . Criteria proposed to use for inclusion/ exclusion of patients and clinical outcome.
Surgical technique, results and limits

Operative technique
Hemicraniectomy for supratentorial infarction usually involves aggressive bone removal to alleviate better the symptoms of malignant cerebral oedema. The need for a radical approach, extension of bone removal, was recognized in the event of severe posttraumatic cerebral oedema, this was echoed in the case of massive cerebral ischemia when a few of initial surgically treated patients harboured a bone defect that was too small, not providing adequate space for decompression and resulting in brain herniation through the skull opening. (25, 60) Prolapsed of the oedematous brain through the edges of the craniectomy defect, with possible exacerbation of brain damage is one of the possible limitations of decompressive craniectomy. In the case of cerebral infarction, however, this phenomenon does not result in significant increased cerebral damage or venous stasis, because most likely the protruding tissue is already necrotic. In the event of massive cerebral ischemia, the frontal, temporal, and parietal bones overlying the infracted hemisphere are removed. The dura is incised and reflected. A dural expansion graft of pericranium, lyophilized cadaver dura, homologous temporal fascia, or sintetic material is loosely sutured to the dura edges to prevent cortical adhesions. The dura is fixed to the craniectomy edges to prevent or limit epidural bleeding, and the temporal muscle and skin flap are reapproximated and sutured or stapled into place. The bone flap may be frozen and preserved or instead a fabricated artificial material can be used (e,g titanium), to close the bone defect, cranioplasty is then performed at a later date, when functional recovery has stabilized. A technical note "In-window" craniotomy and "bridgelike" duraplasty as an alternative to decompressive hemicraniectomy has been lately introduced as an alternative, concluding that decompressive surgery, which uses an in-window craniotomy that gradually opens according to the intracranial pressure, is an alternative solution for deploying autologous material. The procedure has the advantage of obviating the need for a second surgical procedure to close the bone defect, and thus preventing the metabolic cerebral impairment associated with the absence of an overlying skull. (73) By studying the impact of craniectomy size, shape, and location on parenchymal hemorrhagic and ischemic lesions, postoperative bleeding, and mortality, and interestingly found a 70% rate of hemicraniectomy-associated infarcts and hemorrhage. Bleeding was associated with a small craniectomy size and sharp bone defects. Parenchymal hemorrhage was the only factor that statistically affected mortality rate, with only 55% of patients surviving compared with 80% in the absence of hemorrhage, with a recommendation for craniectomy size in a diameter larger than 12 cm. This conclusion is validated by the fact that some studies suggest that doubling the diameter from 6 cm to 12 cm potentially increases the decompressive volume from 9 to 86 ml. (75, 79) Ideally, hemicraniectomy should be performed in the frontotemporoparietal region and reach the floor of the middle cranial fossa. The midline should be spared to avoid injury to the superior sagittal sinus.
Results of craniectomy
For more than 50 years, (1, 10, 39, 66) patients have been selected from case reports or series; range age 10 to 76 years, predominantly male patients, with a good outcome for up to 60% of the patients, several studies have shown that decompressive surgery is a possible treatment strategy for increased ICP after severe supratentorial stroke. Although increasing numbers of studies have reported encouraging results after decompressive craniectomy for ischemic stroke, these studies are mostly limited to case series without a control group, a summery has is shown in a publication. (50) Study shows that mortality is lower in the surgically treated group compared with a higher mortality rate in the control group -medically treated, and with a better outcome in the surgically treated group. (60) As decompressive craniectomy can be a life-saving procedure in patients who will most likely be left with a significant neurological deficit, the operation has important ethical and psychological implications. Because of their altered level of consciousness, patients cannot directly provide consent and in such cases, informed consent has to be obtained from the relatives. Psychological disturbances in this patient population were addressed, and mood disturbances were significant in patients who underwent decompressive craniectomy after right-sided hemisphere ischemic stroke, patients suffered severe depressive symptoms, and mild to moderate impairment was demonstrated. (7) In deciding when surgery is indicated, it is important to know that in general, clinical signs precede critically raised ICP, drowsiness is one of the major clinical symptoms of developing brain oedema (61) thus, ICP monitoring of this condition might be helpful in guiding further therapy. However, elevated ICP is not a common cause of initial neurological deterioration from large hemispheric stroke. (21) Even under full supportive therapy, the mortality rate is reported high (roughly 80%), and lately the effectiveness of many medical therapies such as chronic hyperventilation, osmotherapeutics, barbiturate therapy, has been challenged. (14, 20, 29, 34, 45) The clinical course of patients with severe supratentorial stroke is highly predictable, therefore, waiting for mesencephalic signs to occur potentially worsens prognosis. It was hypothesized that through decompressive surgery, the vicious circle of extensive oedema, which by elevation of ICP causes ischemia of neighbouring brain tissue and further infarction, may be interrupted. (14) This may then increase cerebral perfusion pressure and optimize retrograde perfusion of leptomeningeal collateral vessels, thus allowing functionally compromised but viable brain to survive. (21) The timing of surgery, hemisphere infarcted, presence of signs of herniation before surgery, and involvement of other vascular territories may not significantly affect outcome, to identify the patients most likely to benefit from hemicraniectomy, age may be a crucial factor in predicting functional outcome after hemicraniectomy in patients with large MCA territory infarction, as from different review of data. (26, 33, 47, 60) There are several limits to these reviews.
What limits?
These were data prior to RCTs but in the absence of randomized controlled data by that time, questions remained regarding optimal patient selection, timing of therapy, and prognosis.
Waiting for signs of herniation may worsen prognosis because of irreversible mesencephalic injury. Early decompressive surgery may further improve outcomes in these patients, considering for surgery nondominant hemisphere or incomplete aphasia before deterioration. For the patients, surgically treated before the occurrence of clinical signs of herniation, within the first 24 hours after stroke onset, hemicraniectomy is an effective therapy for the condition of malignant MCA infarction. Most related complications associated with the operation were epidural haematoma, subdural haematoma, and hygromas. However, whether and when decompressive surgery is indicated in these patients is still a matter of debate but, younger patients may have better functional outcome even if undergoing decompressive craniectomy of the dominant hemisphere. 
Surgery-related complications and the quality of life related surgery
Complications have been reported. The outcomes of patients undergoing decompressive craniectomy may be impacted by the complications of the procedure, reported complications include inadequate decompression, infection, hemorrhage, and the development of contralateral fluid collections, postoperative epidural and subdural haemorrhage as well as hygromas has occurred. Furthermore, delayed sinking flap syndrome may result in headaches, seizure and focal neurological deficits and is typically cured by replacement of the bone flap. Similarly, hydrocephalus may develop in a delayed fashion. (7, 28, 29, 34, 45, 60, 65, 71, 77) Available data are in agreement on a reduction of the mortality rate, but the reported functional outcome was highly variable. Older age, more severe neurological deficit on admission, and longer duration of intensive care treatment and mechanical ventilation were significantly associated with worse disability (BI < 50). The health-related quality of life (QOL) was considerably impaired in the subscales of mobility, household management, and body care. Decompressive hemicraniectomy improves survival in patients with malignant MCA infarction when compared with earlier reports of conservative treatment alone. Functional outcome and QOL remain markedly impaired, especially among elderly patients and in those with a severe neurological deficit at admission. (18) Early death is a result of transtentorial herniation while delayed death is typically due to the medical complications of prolonged hospitalization including pneumonia and pulmonary emboli. (67) Although the impact on mortality appeared unequivocal in most studies. Surgical age limit has not yet been fully defined very few data exist to support hemicraniectomy for patients older than 60 years. Data analysis, demonstrate significant mortality reduction in the surgically treated patients compared with those receiving medical treatment. Surgical decompression within 48 hours of stroke onset reduces the risk of death and the risk of significant morbidity and showed a statistically significant reduction in severely disabled, bedridden patients (mRS score > 4), effect on severe disability (mRS score 5) and effect on moderate disability (mRS score 4). (72, 34, 30) Quality of life issues are difficult to put in proper perspective, studies help clarify some facets of this important subject. Future studies will need to focus more rigorously on the long-term quality of life in survivors and the neurological outcome. There exists a difficult balance between increasing survival and poor neurological outcome, which at the other end includes the subjective assessment of outcome and discussion with the patient and the family that should be held early, in the need for surgical decompression, while keeping in mind that RCTs reported a trend of reduced disability among survivors. (72, 34, 30, 55, 68) Data refer that most patients remain in a vegetative state after this intervention, (11) however other data conclude that decompressive hemicraniectomy improves survival in patients with malignant MCA infarction when compared with earlier reports of conservative treatment alone. Functional outcome and QOL remain markedly impaired, especially among elderly patients and in those with a severe neurological deficit at admission. (3, 4, 8, 18, 33) 
Conclusions
Malignant cerebral ischemia occurs in a significant number of patients who undergo emergency evaluation for ischemic stroke. The mortality rate in these patients is very high. Fatal outcome is usually related to progressive, severe cerebral oedema with brain herniation and compression of critical brainstem structures. This patient population can be identified by early clinical and neuroimaging characteristics. In some of these patients, decompressive craniectomy appears to be a life-saving procedure. If craniectomy is performed early, especially in young patients, a satisfactory functional outcome can be achieved in a significant proportion of cases. Questions persist regarding the indications for such a procedure in patients with dominant infarctions. Clinical experience, however, demonstrates that even in such patients, an acceptable functional outcome can be achieved after surgery if some preservation of speech is present at the time of intervention. Best Medical Treatment or Optimal medical management for malignant edema due to stroke has not been standardized. Recommendations for medical management of stroke-related malignant edema included admission to the intensive care unit, osmotherapy with mannitol or glycerol, invasive monitoring of intracranial pressure, blood pressure control, elevation of the head to 30°, and maintenance of normothermia, normoglycemia, and normovolemia. Morbidity and mortality rates are high for this disease entity despite such aggressive measures. (30) Although decompressive craniectomy has been shown to significantly decrease mortality, high morbidity rates among survivors have tempered enthusiasm for this procedure. This reluctance has been most pronounced in elderly patients and those with dominant hemisphere infarcts. The span of the optimal operative time window when surgical decompression is superior to medical management alone is also subject to debate.
We hope that our findings will add to existing information on decompressive hemicraniectomy and help until further data are available. However, there are some unanswered questions and questions persist regarding the age and the indications for such a procedure in patients with dominant infarctions:
• Which subset of patients will benefit maximally? • Which patients will survive with an unacceptable degree of functional dependency? • What is the optimal timing for surgery? MCA infarction with malignant edema is a devastating disease for which hemicraniectomy can play a positive role. Acknowledgement: To our patients, to whom we dedicate a very important part of our lives. To our professors who taught us how to treat our patients. As disclosure, on behalf of the authors, I report no conflict of interest concerning the materials or methods used in our work or the findings specified. 
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